Rani Therapeutics Holdings (RANI) Return on Equity [ROE] (2021 - 2026)
Rani Therapeutics Holdings (RANI) posted Return on Equity [ROE] of -80.09% for Q2 2026, up 14.00 percentage points from the prior quarter.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Return on Equity [ROE] (2021 - 2026) Analysis & Trends
For FY2025, Rani Therapeutics Holdings' Return on Equity [ROE] came in at -182.20%, up 208.90 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a four-year change of +1108.22 percentage points (FY2021 to FY2025).
- In prior years, Rani Therapeutics Holdings' Return on Equity [ROE] was -391.10% in FY2024 (-254.58 pp), -136.52% in FY2023 (-71.74 pp), -64.78% in FY2022 (+1225.64 pp) and -1290.42% in FY2021.
- The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q4 2022.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2022, with a gain of 1069.63 percentage points; the weakest was Q4 2024, with a drop of 995.77 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | - |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 4.97% |
| 10 | Rani Therapeutics Holdings | 110.43 Mn | -381,884.91 | - | -80.09% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -80.09% |
| Mar 31, 2026 | -94.10% |
| Dec 31, 2025 | -277.44% |
| Dec 31, 2024 | -1,221.06% |
| Sep 30, 2024 | -969.84% |
| Jun 30, 2024 | -602.71% |
| Mar 31, 2024 | -329.33% |
| Dec 31, 2023 | -225.29% |
| Sep 30, 2023 | -171.52% |
| Jun 30, 2023 | -125.81% |
| Mar 31, 2023 | -97.86% |
| Dec 31, 2022 | -78.88% |
| Sep 30, 2022 | -64.03% |
| Jun 30, 2022 | -68.61% |
| Mar 31, 2022 | -52.81% |
| Dec 31, 2021 | -41.92% |
| Sep 30, 2021 | -1,133.66% |
API Access
Rani Therapeutics Holdings Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();